Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes
Related Experiment Video
Updated: Jul 11, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Emily A Rosenberg1,2, Ellen W Seely1,2
1Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
Insights
Adverse pregnancy outcomes like gestational diabetes and preeclampsia are key cardiovascular disease risk factors in women. Early identification and management of these conditions can aid in cardiovascular risk reduction.
Area of Science:
- Cardiology
- Obstetrics & Gynecology
- Reproductive Health
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in women.
- Adverse pregnancy outcomes (APOs), including gestational diabetes (GDM) and preeclampsia, are significant CVD risk factors unique to women.
- APOs often go unrecognized by healthcare providers, missing opportunities for early intervention.
Approach:
- This mini-review synthesizes current knowledge on GDM and preeclampsia.
- It explores the link between APOs and CVD, including underlying mechanisms.
- Management strategies, both pharmacological and non-pharmacological, are discussed for clinicians.
Key Points:
- Gestational diabetes and preeclampsia are critical indicators of future cardiovascular risk.
- Understanding the pathophysiological links between APOs and CVD is essential for risk assessment.
- Proactive management of women with a history of APOs can mitigate long-term cardiovascular risks.
Conclusions:
- APOs represent a crucial window for assessing and managing a woman's lifetime cardiovascular disease risk.
- Clinicians should routinely inquire about pregnancy history to identify at-risk individuals.
- Implementing targeted interventions post-APO can significantly improve women's cardiovascular health outcomes.
Abstract:
Cardiovascular disease (CVD) is the leading cause of death among women. Adverse pregnancy outcomes (APOs) are cardiovascular risk factors that are unique to women and include gestational diabetes (GDM) and preeclampsia. While these risk factors emerge during the reproductive years and allow for early risk reduction counseling, they are often overlooked and not elicited by providers. This mini-review focuses primarily on GDM and preeclampsia, their relationship with CVD, mechanisms by which these conditions lead to CVD, and management, pharmacological and nonpharmacological, for the clinician who is caring for a woman with a history of an APO.
Related Concept Videos
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Mitral Valve Prolapse III: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care

